Talk to the Institute
Published mark

BICYCLE THERAPEUTICS PLC

NASDAQ: BCYC. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c
SEC CIK
0001761612
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
Newest evidence
Apr 22, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Kevin Lee, Ph.D., MBASince Apr 22, 2026
Chair
Not published
Independent
6 / 88 directors published
Published claims
302 distinct sources
Evidence records
90 pinned
Source conflicts
0None open

Built from 2 distinct sources and 9 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Alistair Milnes executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.

EffectiveEffective Apr 22, 2026E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Corporate Development OfficerAlistair MilnesApr 2026currentSource reportedE3
Chief Operating OfficerJennifer Perry, Pharm.D.Apr 2026currentSource reportedE4
Chief Executive Officer and DirectorKevin Lee, Ph.D., MBAApr 2026currentSource reportedE5
Chief Product and Supply Chain OfficerMichael Hannay, D.Sc.Apr 2026currentSource reportedE6
Chief Scientific OfficerMichael Skynner, Ph.D.Apr 2026currentSource reportedE7
Chief Financial OfficerTravis ThompsonApr 2026currentSource reportedE8

Board of directors

Evidence

8 directors published. 6 of 8 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Alessandro Riva, M.D.Independent2025None publishedSource reportedE2
Charles Swanton, M.D., Ph.D., FRS, FMedSci, FRCPNot independent2025None publishedSource reportedE2
Felix J. Baker, Ph.D.Independent2024None publishedSource reportedE2
Hervé HoppenotIndependent2025AuditAudit; CompensationCompensationSource reportedE2
Jose-Carlos Gutierrez-Ramos, Ph.D.Independent2021None publishedSource reportedE2
Kevin Lee, Ph.D., MBANot independent2015None publishedSource reportedE2
Roger Dansey, M.D.Independent2025None publishedSource reportedE2
Stephen Sands, MBAIndependent2024Audit, chairAudit · Chair; CompensationCompensationSource reportedE2
Janice Bourque, MBAIndependentNot publishedAuditAudit; Compensation · Chair; Nominating and GovernanceCompensation, chairNominating and GovernanceSource reportedE2
Sir Gregory Winter, FRSIndependentNot publishedNone publishedSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditStephen Sands, MBAStephen Sands, MBA, Hervé Hoppenot, Janice Bourque, MBANot described in the published record
Audit · Chair; CompensationNot publishedStephen Sands, MBANot described in the published record
Audit; CompensationNot publishedHervé HoppenotNot described in the published record
Audit; Compensation · Chair; Nominating and GovernanceNot publishedJanice Bourque, MBANot described in the published record
CompensationJanice Bourque, MBAJanice Bourque, MBA, Hervé Hoppenot, Stephen Sands, MBANot described in the published record
Nominating and GovernanceNot publishedJanice Bourque, MBANot described in the published record
Committee RecordAudit: Chair Stephen Sands, MBA; Members Stephen Sands, MBA (Chair); Hervé Hoppenot; Janice Bourque, MBA
Source reportedE9
company:dd253d48-d76e-4741-99ec-ebff7299889c:committee_record:21
Committee AppointmentStephen Sands, MBA: chair, Audit
Source reportedE9
company:dd253d48-d76e-4741-99ec-ebff7299889c:committee_appointment:22
Committee AppointmentHervé Hoppenot: member, Audit
Source reportedE9
company:dd253d48-d76e-4741-99ec-ebff7299889c:committee_appointment:23
Committee AppointmentJanice Bourque, MBA: member, Audit
Source reportedE9
company:dd253d48-d76e-4741-99ec-ebff7299889c:committee_appointment:24
Committee RecordCompensation: Chair Janice Bourque, MBA; Members Janice Bourque, MBA (Chair); Hervé Hoppenot; Stephen Sands, MBA
Source reportedE9
company:dd253d48-d76e-4741-99ec-ebff7299889c:committee_record:25
Committee AppointmentJanice Bourque, MBA: chair, Compensation
Source reportedE9
company:dd253d48-d76e-4741-99ec-ebff7299889c:committee_appointment:26
Committee AppointmentHervé Hoppenot: member, Compensation
Source reportedE9
company:dd253d48-d76e-4741-99ec-ebff7299889c:committee_appointment:27
Committee AppointmentStephen Sands, MBA: member, Compensation
Source reportedE9
company:dd253d48-d76e-4741-99ec-ebff7299889c:committee_appointment:28
Committee RecordNominating and Governance: Chair not stated; Members Janice Bourque, MBA
Source reportedE9
company:dd253d48-d76e-4741-99ec-ebff7299889c:committee_record:29
Committee AppointmentJanice Bourque, MBA: member, Nominating and Governance
Source reportedE9
company:dd253d48-d76e-4741-99ec-ebff7299889c:committee_appointment:30

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerKevin Lee, Ph.D., MBA, Chief Executive Officer and Director, from Apr 22, 2026
Source reportedE5
company:dd253d48-d76e-4741-99ec-ebff7299889c:leadership_role:17
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingBCYC (NASDAQ)
Source reportedE1
company:dd253d48-d76e-4741-99ec-ebff7299889c:security_listing:31
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameBICYCLE THERAPEUTICS PLC
Source reportedE1
company:dd253d48-d76e-4741-99ec-ebff7299889c:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:dd253d48-d76e-4741-99ec-ebff7299889c:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
9 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    BICYCLE THERAPEUTICS PLC DEF 14A 2026-04-22
    sec proxy. Published Apr 22, 2026. Retrieved Apr 24, 2026. Cited by 10 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    BCYC DEF 14A executive officers
    sec filing. Published Apr 22, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    BCYC DEF 14A executive officers
    sec filing. Published Apr 22, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    BCYC DEF 14A executive officers
    sec filing. Published Apr 22, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    BCYC DEF 14A executive officers
    sec filing. Published Apr 22, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    BCYC DEF 14A executive officers
    sec filing. Published Apr 22, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    BCYC DEF 14A executive officers
    sec filing. Published Apr 22, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    Audit
    board_seats. board seats. Cited by 10 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026
  • Alistair Milnes executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.
  • Jennifer Perry, Pharm.D. executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.
  • Kevin Lee, Ph.D., MBA executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.
  • Michael Hannay, D.Sc. executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.
  • Michael Skynner, Ph.D. executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.
  • Travis Thompson executive of BICYCLE THERAPEUTICS PLC, effective 2026-04-22.
  • Alessandro Riva, M.D. seat on BICYCLE THERAPEUTICS PLC, effective 2025-01-01.
  • Charles Swanton, M.D., Ph.D., FRS, FMedSci, FRCP seat on BICYCLE THERAPEUTICS PLC, effective 2025-01-01.
  • Hervé Hoppenot seat on BICYCLE THERAPEUTICS PLC, effective 2025-01-01.
  • Roger Dansey, M.D. seat on BICYCLE THERAPEUTICS PLC, effective 2025-01-01.
  • Audit; Compensation committee of BICYCLE THERAPEUTICS PLC, effective 2025-01-01.
  • Hervé Hoppenot member of Audit; Compensation, effective 2025-01-01.
  • Felix J. Baker, Ph.D. seat on BICYCLE THERAPEUTICS PLC, effective 2024-01-01.
  • Stephen Sands, MBA seat on BICYCLE THERAPEUTICS PLC, effective 2024-01-01.
  • Audit · Chair; Compensation committee of BICYCLE THERAPEUTICS PLC, effective 2024-01-01.
  • Stephen Sands, MBA member of Audit · Chair; Compensation, effective 2024-01-01.
  • Jose-Carlos Gutierrez-Ramos, Ph.D. seat on BICYCLE THERAPEUTICS PLC, effective 2021-01-01.
  • Kevin Lee, Ph.D., MBA seat on BICYCLE THERAPEUTICS PLC, effective 2015-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:dd253d48-d76e-4741-99ec-ebff7299889c, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/bicycle-therapeutics-plc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership6
  4. Board10
  5. Committees6
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people15
  17. Subject and corrections6
  18. Evidence9
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:dd253d48-d76e-4741-99ec-ebff7299889c
  • Cite this recordBICYCLE THERAPEUTICS PLC
  • Copy canonical URLregistry.alpha.ac/companies/bicycle-therapeutics-plc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    BICYCLE THERAPEUTICS PLCCompany
  • Alistair MilnesPerson
  • Jennifer Perry, Pharm.D.Person
  • Kevin Lee, Ph.D., MBAPerson
  • Michael Hannay, D.Sc.Person
  • Michael Skynner, Ph.D.Person
  • Travis ThompsonPerson
  • Alessandro Riva, M.D.Person
  • Charles Swanton, M.D., Ph.D., FRS, FMedSci, FRCPPerson
  • Felix J. Baker, Ph.D.Person
  • Hervé HoppenotPerson
  • Jose-Carlos Gutierrez-Ramos, Ph.D.Person
  • Roger Dansey, M.D.Person
  • Stephen Sands, MBAPerson
  • Janice Bourque, MBAPerson
  • Sir Gregory Winter, FRSPerson
  • Sections
    OverviewBICYCLE THERAPEUTICS PLC
  • MonitoringBICYCLE THERAPEUTICS PLC
  • LeadershipBICYCLE THERAPEUTICS PLC
  • BoardBICYCLE THERAPEUTICS PLC
  • CommitteesBICYCLE THERAPEUTICS PLC
  • Control and votingBICYCLE THERAPEUTICS PLC
  • Authority to actBICYCLE THERAPEUTICS PLC
  • FinancialsBICYCLE THERAPEUTICS PLC
  • GovernanceBICYCLE THERAPEUTICS PLC
  • RiskBICYCLE THERAPEUTICS PLC
  • AI oversightBICYCLE THERAPEUTICS PLC
  • LegalBICYCLE THERAPEUTICS PLC
  • CompensationBICYCLE THERAPEUTICS PLC
  • Other published claimsBICYCLE THERAPEUTICS PLC
  • Coverage gapsBICYCLE THERAPEUTICS PLC
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.